Tactile Systems (TCMD) Technology announced that Nimbl, its next-generation pneumatic compression platform, is now commercially available throughout the United States for the treatment of both upper and lower extremity lymphedema. Nimbl’s expanded availability to include lower extremity conditions follows its commercial introduction in October 2024, initially focused on treating patients suffering from upper extremity lymphedema.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCMD:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue